Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Abstract
The major known genetic risk for Alzheimer's disease (AD), apolipoprotein E-4 (APOE-4), is associated with lowered parietal, temporal, and posterior cingulate cerebral glucose metabolism in patients with a clinical diagnosis of AD. To determine cognitive and metabolic decline patterns according to genetic risk, we investigated cerebral metabolic rates by using positron emission tomography in middle-aged and older nondemented persons with normal memory performance. A single copy of the APOE-4 allele was associated with lowered inferior parietal, lateral temporal, and posterior cingulate metabolism, which predicted cognitive decline after 2 years of longitudinal follow-up. For the 20 nondemented subjects followed longitudinally, memory performance scores did not decline significantly, but cortical metabolic rates did. In APOE-4 carriers, a 4% left posterior cingulate metabolic decline was observed, and inferior parietal and lateral temporal regions demonstrated the greatest magnitude (5%) of metabolic decline after 2 years. These results indicate that the combination of cerebral metabolic rates and genetic risk factors provides a means for preclinical AD detection that will assist in response monitoring during experimental treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, oxidative stress, mitochondrial dysfunction, and glucose hypometabolism have been well documented in MCI and AD brain [8,53,74,75,76].”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [74]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been suggested that this association may account for the earlier onset of symptoms in E4 carriers (21–23).”
From Prediction of cognitive decline in normal elderly subjects with 2-[ 18 F]fluoro-2-deoxy- d -glucose/positron-emission tomography (FDG/PET) (2001) · cites this paper as [23]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Young, cognitively normal apoE4 carriers have glucose hypometabolism in brain regions affected by AD [29–31]”
From Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function (2019) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This suggests the possibility that an apoE-related decrease in brain metabolism may contribute to development of AD (Reiman et al., 1996; Reiman et al., 2004, 2005; Small et al., 2000).”
From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Small et al., 2000
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, studies looking at both young and old non-demented carriers of the apoE4 isoform observed a similar regional pattern of hypometabolism prior to the onset of disease that correlates with the changes seen in the AD brain.”
From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Small et al., 2000
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
Statistical parametric maps in functional imaging: A general linear approach
Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J. ‐., Frith, C. D., & Frackowiak, R. S. J. (1994) · Human Brain Mapping · doi:10.1002/hbm.460020402 · Cited by 9,688
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Self-citationMild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Talairach, J., Tournoux, P., & Rayport, M. (1988) · Thieme eBooks · Cited by 5,058
Spatial registration and normalization of images
Friston, K. J., Ashburner, J., Frith, C. D., Poline, J. ‐., Heather, J. D., & Frackowiak, R. S. J. (1995) · Human Brain Mapping · doi:10.1002/hbm.460030303 · Cited by 4,028
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Self-citationPopulation-Based Norms for the Mini-Mental State Examination by Age and Educational Level
Crum, R. M. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500180078038 · Cited by 2,929
Research works printed but not linked: 3
- Rogers, S. L. & Friedhoff, L. T. (1996) Dementia 7, 293-303.
- Huang, S. C., Phelps, M. E., Hoffman, E. J., Sideris, K., Selin, C. J. & Kuhl, D. E. (1980) Am. J. Physiol. 238, E69-82.
- Benton, A. L. (1974) The Revised Visual Retention Test (Psychological Corp., New York).
Cited by
Items 701–796 of 796
Elgh, E. (2004) · DiVA at Umeå University (Umeå University)
Lam, L. C. W., & Small, G. W. (2002)
Self-citationFunctional Activation Studies in Alzheimer Patients and Strategies in Drug Evaluation
Nordberg, A. K. (2002) · Advances in behavioral biology · doi:10.1007/978-0-306-47593-1_30
Postmitochondrial regulation of apoptosis in neurons and cancer cells
Vaughn, A. E. (2007) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvyq-7s62
Validating MRI Measures of Disease Stage and Progression in Alzheimer’s Disease
Jack, C. R. (2004) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-59300-0_7
“Some data are available indicating that serial measures of glucose metabolism from FDG PET may be useful (Small et al. 2000; Reiman et al. 2001).”
BackgroundDementia and Alzheimer Disease: Evidence-Based Neuroimaging
Gutierrez, J. E., Eichinger, B., & Kantarci, K. (2013) · Springer eBooks · doi:10.1007/978-1-4614-3320-0_17
Pathological Consequences of Aβ From Extracellular to Intraneuronal
D’Andrea, M. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804256-4.00004-8
10 Neuroimaging in Alzheimer Disease
Kantarci, K., & Jack, C. R. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7777-9_10
Bagheri, T., Bennett, V., Buck, A., Gordge, K., Green, I., Kang, E., Kim, N., McCue, C., Mehta, U., Morken, S., et al. (2016) · University Libraries (University of Maryland) · doi:10.13016/m2120n
18 Functional MRI Studies in Aging and Early Alzheimer’s Disease: Predicting Clinical Decline
Sperling, R. A. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195328875.003.0018
PET Imaging as a Diagnostic Tool in Alzheimer’s Disease
Rinne, J. O. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3560-4_13
Pharmacogenetics of Late-Life Depression
Murphy, G. M. (2013) · Oxford University Press eBooks · doi:10.1093/med/9780199796816.003.0037
Goodwin, L. (2006) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-56632-7_7
9 Genetics and Imaging in Alzheimer’s Disease
Bookheimer, S. Y. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195328875.003.0009
Self-citationThornton‐Wells, T. A. (2006) · Europe PMC (PubMed Central)
Phenotypic Impact of Genetic Risk Pathways for Alzheimer's Disease
Felsky, D. (2016) · TSpace (University of Toronto)
Diagnosis of Alzheimer’s disease
Rosa‐Neto, P., Rowley, J., Leuzy, A., Mohades, S., Shin, M., Dauar, M. T., & Gauthier, S. G. (2012) · doi:10.2217/ebo.12.66
FDG-PET in Alzheimer’s Disease
Inui, Y., Ito, K., & Kato, T. (2017) · Springer eBooks · doi:10.1007/978-4-431-55133-1_9
Metabolic study of Alzheimer’s disease using mutant C. elegans
Ahmad, W. (2017) · The University of Queensland · doi:10.14264/uql.2017.500
“In AD, reduced, CMRglc has been reported in hippocampus, parietal-temporal and prefrontal regions within the brain when compared with agematched health individuals [208, 209].”
ResultImaging CNS Disease States: Alzheimer’s Disease
Dickerson, B. C. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0134-7_19
“2001) and subjects with mild memory impairment who carry the APOE-e4 allele (Small et al. 2000).”
BackgroundCognitive Deficits in Neurodegenerative Disorders: Parkinson’s Disease and Alzheimer’s Disease
Bodis-Wollner, I. G., & Moreno, H. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_9
Mondadori, C. (2006) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-163345
Kaira, M., Ahlawat, A., Walia, V., & Garg, M. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-1317-0.ch002
Burggren, A. C., & Bookheimer, S. Y. (2007) · Elsevier eBooks · doi:10.1016/b0-12-370870-2/00137-2
Self-citationNovel stable isotope methods to quantify glucose metabolism
Wall, M. L. (2016)
PPARγ Agonists for the Treatment of Alzheimer's Disease
Jiang, Q., Mandrekar, S., & Landreth, G. E. (2007) · Springer eBooks · doi:10.1007/7355_2007_014
Meyer, P. T., Rijntjes, M., & Weiller, C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0434-1.00037-2
(2010) · Wiley eBooks · doi:10.1002/9780470689394.refs
Pathogenesis of Alzheimer Disease: Metabolic Factors
(2004) · Springer eBooks · doi:10.1007/0-306-48529-x_15
Applications of fMRI to Neurodegenerative Disease
Mahmoud, S. Y., Jones, S. E., & Phillips, M. D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1995-6_18
(2007) · Elsevier eBooks · doi:10.1016/b978-012373657-4/50008-8
Ainslie, P. N. (2014) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718270401.793490776
Селезнева, Н. Д., & Рощина, И. Ф. (2017) · Psikhiatriya · doi:10.30629/2618-6667-2017-76-27-36
Elgazzar, A. H., & Sarikaya, İ. (2024) · Springer eBooks · doi:10.1007/978-3-031-68074-8_8
Drosophila pyruvate kinase links metabolic state with circadian output via TARANIS and PDF
Lee, S., Akpoghiran, O., Kang, S. W., Cho, E., Ahn, J. M., Kang, M., Koh, K., & Kim, E. Y. (2026) · Communications Biology · doi:10.1038/s42003-026-10873-x · Cited by 1
Appendixe B: Level of Function Scale
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.app02
Chapter 20. Supporting Family Caregivers
Gallagher-Thompson, D. E., Lonergan, K. H., Holland, J. M., China, D., & Ashford, J. W. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg20 · Cited by 1
Chapter 1. Dementia and Alzheimer Disease: Ancient Greek Medicine to Modern Molecular Biology
Weiner, M. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg01 · Cited by 2
Appendixe C: Mental Status Examination
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.app03
Chapter 13. Traumatic Brain Injury
Bigler, E. D. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg13 · Cited by 3
Appendixe E: Alzheimer’s Disease Cooperative Study: Activities of Daily Living Inventory
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.app05
Chapter 22. Ethical Issues and Patterns of Practice
Hughes, J. C. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg22
Frolik, L. A. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg21
Chapter 14. Other Causes of Dementia
ZAMRINI, E. Y., & Quiceno, M. E. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg14 · Cited by 1
Appendixe G: Agitated Behavior in Dementia Scale
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.app07
Chapter 23. Biomarkers for the Dementias
Bürger, K., & Hampel, H.-J. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg23
Chapter 16. Pharmacological Treatment of Neuropsychiatric Symptoms
Yaari, R., & Tariot, P. N. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg16
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.app10
Chapter 19. Management of Advanced Dementia
Volicer, L., & Simard, J. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg19 · Cited by 1
Appendixe D: Neurological Examination
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.app04
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.fm02
Chapter 17. Behavioral and Environmental Management
Hilgeman, M. M., Burgio, L. D., & Allen, R. S. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg17 · Cited by 1
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.fm05
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.app01
Chapter 3. Neuropsychiatric Assessment and Diagnosis
Weiner, M., Garrett, R., & Bret, M. E. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg03
Chapter 7. Cognitive Disorders as Psychobiological Processes
Weiner, M. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg07
Chapter 12. Frontotemporal Dementia
Lipton, A. M., & Boxer, A. L. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg12 · Cited by 1
Appendixe F: Neuropsychiatric Inventory: Community Dwelling Version
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.app06
Chapter 11. Dementia With Lewy Bodies and Other Synucleinopathies
Tarawneh, R. M., & Galvin, J. E. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg11 · Cited by 2
Chapter 5. Neuropsychological Assessment in Dementia
Cullum, C. M., & Lacritz, L. H. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg05 · Cited by 1
Chapter 2. Epidemiology and Impact of Dementia
Savva, G. M., & Brayne, C. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg02 · Cited by 3
Appendixe I: Quality of Life in Late-Stage Dementia (QUALID) Scale
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.app09
Chapter 4. Medical Evaluation and Diagnosis
Lipton, A. M., & Rubin, C. D. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg04
Chapter 24. The Molecular and Genetic Basis of Alzheimer Disease
Rosenberg, R. N. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg24
Chapter 10. Vascular Cognitive Disorder
Szoeke, C. E. I., Campbell, S., Chiu, E. Y.-K., & Ames, D. J. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg10 · Cited by 3
Geldmacher, D. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg08 · Cited by 2
Chapter 18. Pharmacological Treatment of Alzheimer Disease and Mild Cognitive Impairment
Farlow, M. R., & Boustani, M. A. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg18 · Cited by 2
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.fm01
Chapter 26. Prevention of Dementia and Cognitive Decline
Breitner, J. C. S., & Albert, M. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg26
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.fm04
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.fm03
Appendixe H: Quality of Life in Alzheimer’s Disease Scale
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.app08
Chapter 9. Mild Cognitive Impairment
Geda, Y. E., Negash, S., & Petersen, R. C. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg09
Foster, N. L. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg06
Chapter 25. The Future of Dementia Treatment
Sano, M. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.lg25
Tai, Y., & Piccini, P. P. (2006) · Springer eBooks · doi:10.1007/1-84628-187-3_28 · Cited by 1
Farmer, B. C., Williams, H. C., Devanney, N. A., Piron, M. A., Nation, G. K., Carter, D. J., Walsh, A. E., Khanal, R., Young, L. E. A., Kluemper, J. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16575414
ApoE4 effects on the structural covariance brain networks topology in Mild Cognitive Impairment
Sanabria-Díaz, G. (2021) · IRIS
CASALI, E. (2018) · Electronic Theses and Dissertations Repository (University of Pisa)
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585628940.index
Hanse, M. (2011) · theses.fr (ABES) · doi:10.70675/0a6de16dz1681z48b0zada8zd0b0d5d3e6b9 · Cited by 1
Piquet, J. (2017) · theses.fr (ABES) · doi:10.70675/4d01ccd7zf07ez4d19z9665zd5ad6117599e
Poulot-Becq-Giraudon, Y. (2024) · theses.fr (ABES) · doi:10.70675/0d7a8b92z8393z4d76z82a8z87efe0790346
Mahley, R. W. (2026) · Springer eBooks · doi:10.1007/978-3-031-96089-5_2
First characterization of metabolomic and lipidomic exchange over the healthy human brainPreprint
Vrdoljak, D., Caldwell, H. G., Duffy, J. S., Carr, J. M. J. R., Brewster, L. M., Magaña, A. A., Rasmussen, P., Gibbons, T. D., MacLeod, D. B., & Ainslie, P. N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.16.732772
“However, it is well known that a drop in brain glucose metabolism occurs in advance of cognitive decline (Jagust et al., 2006; Reiman et al., 2004; Small et al., 2000).”
Gonzalez, L. M. (2021) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)
Al‐Ezzi, A. A. A., Wee, C. P., Wu, X., Astraea, N., Kleinman, M. T., Mack, W., Kloner, R. A., & Arakaki, X. (2026) · Neuroimage Reports · doi:10.1016/j.ynirp.2026.100411
“…the right PFC exhibits decreased cerebral blood flow with aging (Lu et al., 2011), metabolic decline associated with episodic memory decline in APOE-4 positive elderlies (Small et al., 2000), and reductions in white matter volume related to neuropsychological performance (Brickman et al., 2006).”
Seleznyova, N. D., If, R., Колыхалов, И. В., & Гаврилова, С. И. (2024) · Современная терапия психических расстройств
Potential links between PCOS/PMOS and Alzheimer disease and related dementias
Amiri, M., Hamidi, A. K., Farkas, D. L., Buyalos, R. P., & Azziz, R. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag206
“This imbalance, combined with metabolic risk factors (36), may drive endothelial dysfunction (123), increased left ventricular mass (125), accelerated atherosclerosis (126), and a prothrom-botic state (127).”
Sasaki, S. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261496507
Huey, N. (n.d.) · USF Scholarship Repository (University of San Francisco)
Holcomb, E. M. (2013) · Human Biology
Greimel, S. J. (2014) · University of Minnesota Digital Conservancy (University of Minnesota)
Saul, A. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3915
Metadata
- Authors
- Small, G. W., Ercoli, L. M., Silverman, D. H. S., Huang, S.-C., Komo, S., Bookheimer, S. Y., Lavretsky, H., Miller, K., Siddarth, P., Rasgon, N. L., Mazziotta, J. C., Saxena, S., Wu, H. M., Mega, M. S., Cummings, J. L., Saunders, A. M., Pericak-Vance, M. A., Roses, A. D., Barrio, J. R., & Phelps, M. E.
- Affiliations
- University of California, Los Angeles (US)
- Center on Aging and Department of Psychiatry and Biobehavioral Sciences, Neuropsychiatric Institute, 760 Westwood Plaza, Los Angeles, CA 90024; Departments of Molecular and Medical Pharmacology and Neurology, and Brain Mapping Center, University of California, Los Angeles, CA 90095; Department of Medicine, Duke University Medical Center, Durham, NC 27710; and Glaxo Wellcome Research and Development, Research Triangle Park, NC 27709
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2000-05-16
- Volume
- 97
- Issue
- 11
- Pages
- 6037-6042
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC18554
- OpenAlex
- W2164303459
- Cited by
- 790
- References
- 53
- Citations by year
- 2026: 13 · 2025: 8 · 2024: 12 · 2023: 17 · 2022: 20 · 2021: 17 · 2020: 24 · 2019: 20 · 2018: 17 · 2017: 22 · 2016: 17 · 2015: 14 · 2014: 27 · 2013: 34 · 2012: 30
- FWCI
- 29.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Energy
- Alzheimer's Association
- Ahmanson Foundation
- National Institutes of Health (AG10123, MH52453, NS26630)
- U.S. Public Health Service
- National Institute on Aging (AG-13308, P50AG016570, P50AG005128, R01AG013308, P60AG011268, P30AG010123, U24AG021886)
- National Institute of Mental Health (MH52453, R01MH052453)
- National Institute of Neurological Disorders and Stroke (P01NS026630, R01NS031153)
- National Center for Research Resources (M01RR000865)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, APOE ε4, genetic risk, brain glucose metabolism, cognitive decline, posterior cingulate cortex, inferior parietal cortex, lateral temporal cortex, preclinical Alzheimer's disease, memory performance, non-demented elderly, longitudinal follow-up
- MeSH terms
- Aged, Aged, 80 and over, Alleles, Alzheimer Disease, Apolipoproteins E, Brain, Cognition Disorders, Female, Follow-Up Studies, Genotype, Humans, Male, Memory Disorders, Middle Aged, Psychological Tests, Risk Factors, Tomography, Emission-Computed, Genetic Predisposition to Disease, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.